To bring together the strengths of the NHS, universities and industry. By fostering creative relationships between these three key stakeholders, we aim to create a much more collaborative environment that supports the translation of laboratory research into real-life impact.
This theme is now under the oversight of the Research and Innovation Oversight Group, chaired by Chas Bountra, and it includes representatives from all partners and the two NIHR BRCs, the NIHR MIC, Oxford University Innovations and a member will also be sought from the Oxford CLAHRC – expected to be redesignated an ARC in April/May 2019.
To reduce the barriers to collaboration, generate better targets for drug discovery, create long-term collaborative relationships, and drive innovation and entrepreneurship, in order to:
- More efficiently translate our fundamental research into benefit for patients
- Facilitate the creation of commercial value for our private partners
- Attract inward investment into the region and the UK
- Create many more high skilled health sector jobs, associated with unique opportunities for education and training
- Create more sustainable biotech companies